1Ruzyllo W,Szwed H,Sadowski Z,ef al.Efficacy of trimetazidine in patients with recurrent angina:a subgroup analysis of the TRIMPOL Ⅱ study[J].Curr Med Res Opin,2004,20:1447-1454.
4Wagner H, Chari VM. Carbon-13NMR Spectra of Nature Flavanoids. Tetrahedron Lett, 1976:1799.
5Duddeck H, Snatzke G, Yemul SS. 13C NMR of Flavanoids from Gareinia Species and of Related Flavonones. Phytochemistry,1978,17 : 1369.
6Markharm KR, Ternai B. 13C NMR of Flavanoids-Ⅱ, Flavanoids Other Then Flavone and Flavonol Aglycone. Tetrahedron, 1976,32(21) :2607.
7Giuseppe M.Sangiorgi,FabrizioClementi,ClarissaCola,GiusseppeBiondi‐Zoccai.Plaque vulnerability and related coronary event prediction by intravascular ultrasound with virtual histology: “It’s a long way to tipperary”?[J].Cathet Cardiovasc Intervent.2007(2)
8Gastón A. Rodriguez-Granillo,Eugène P. Mc Fadden,Marco Valgimigli,Carlos A.G. van Mieghem,Evelyn Regar,Pim J. de Feyter,Patrick W. Serruys.Coronary plaque composition of nonculprit lesions, assessed by in vivo intracoronary ultrasound radio frequency data analysis, is related to clinical presentation[J].American Heart Journal.2006(5)
9Marco A. Costa,Daniel I. Simon.Molecular Basis of Restenosis and Drug-Eluting Stents[J].Circulation.2005(17)
10Pedro A. Lemos,Carlos A.G. van Mieghem,Chourmouzios A. Arampatzis,Angela Hoye,Andrew T.L. Ong,Eugene McFadden,Georgios Sianos,Willem J. van der Giessen,Pim J. de Feyter,Ron T. van Domburg,Patrick W. Serruys.Post–Sirolimus-Eluting Stent Restenosis Treated With Repeat Percutaneous Intervention: Late Angiographic and Clinical Outcomes[J].Circulation: Journal of the American Heart Association.2004(21)
